CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
2.00
10.31%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.09
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Outset Medical Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 2.23
Open* 2.17
1-Year Change* -88.18%
Day's Range* 1.97 - 2.17
52 wk Range 2.90-30.55
Average Volume (10 days) 1.29M
Average Volume (3 months) 25.63M
Market Cap 175.21M
P/E Ratio -100.00K
Shares Outstanding 50.20M
Revenue 131.88M
EPS -3.57
Dividend (Yield %) N/A
Beta 2.09
Next Earnings Date May 1, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 12, 2024 2.00 -0.16 -7.41% 2.16 2.19 1.98
Apr 11, 2024 2.23 -0.11 -4.70% 2.34 2.39 2.23
Apr 10, 2024 2.27 -0.08 -3.40% 2.35 2.40 2.20
Apr 9, 2024 2.46 -0.01 -0.40% 2.47 2.66 2.33
Apr 8, 2024 2.48 0.37 17.54% 2.11 2.56 2.10
Apr 5, 2024 2.01 0.03 1.52% 1.98 2.26 1.95
Apr 4, 2024 1.90 -0.14 -6.86% 2.04 2.05 1.90
Apr 3, 2024 1.99 0.02 1.02% 1.97 2.06 1.91
Apr 2, 2024 1.97 0.00 0.00% 1.97 1.98 1.90
Apr 1, 2024 2.04 -0.16 -7.27% 2.20 2.20 2.04
Mar 28, 2024 2.18 0.01 0.46% 2.17 2.31 2.14
Mar 27, 2024 2.15 -0.02 -0.92% 2.17 2.26 2.15
Mar 26, 2024 2.15 0.12 5.91% 2.03 2.22 2.03
Mar 25, 2024 2.01 0.05 2.55% 1.96 2.07 1.95
Mar 22, 2024 1.95 -0.12 -5.80% 2.07 2.08 1.94
Mar 21, 2024 2.04 -0.15 -6.85% 2.19 2.28 2.04
Mar 20, 2024 2.17 -0.03 -1.36% 2.20 2.22 2.05
Mar 19, 2024 2.22 0.14 6.73% 2.08 2.33 2.03
Mar 18, 2024 1.97 -0.10 -4.83% 2.07 2.09 1.93
Mar 15, 2024 2.13 0.06 2.90% 2.07 2.15 2.02

Outset Medical, Inc. Events

Time (UTC) Country Event
Wednesday, May 1, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 Outset Medical Inc Earnings Release
Q1 2024 Outset Medical Inc Earnings Release

Forecast

-

Previous

-
Wednesday, May 29, 2024

Time (UTC)

20:30

Country

US

Event

Outset Medical Inc Annual Shareholders Meeting
Outset Medical Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Thursday, May 30, 2024

Time (UTC)

20:30

Country

US

Event

Outset Medical Inc Annual Shareholders Meeting
Outset Medical Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, July 31, 2024

Time (UTC)

10:59

Country

US

Event

Q2 2024 Outset Medical Inc Earnings Release
Q2 2024 Outset Medical Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 115.375 102.602 49.935 15.078 2.007
Revenue 115.375 102.602 49.935 15.078 2.007
Cost of Revenue, Total 97.542 94.994 62.972 32.88 8.122
Gross Profit 17.833 7.608 -13.037 -17.802 -6.115
Total Operating Expense 277.761 233.121 168.969 85.385 48.57
Selling/General/Admin. Expenses, Total 129.997 101.386 75.58 29.178 17.532
Research & Development 48.855 36.741 28.85 23.327 22.916
Operating Income -162.386 -130.519 -119.034 -70.307 -46.563
Interest Income (Expense), Net Non-Operating -0.275 -1.217 -2.365 -1.772 -2.93
Other, Net 0 0 -0.093 3.8 -0.262
Net Income Before Taxes -162.661 -131.736 -121.492 -68.279 -49.755
Net Income After Taxes -162.956 -131.935 -121.492 -68.299 -49.78
Net Income Before Extra. Items -162.956 -131.935 -121.492 -68.299 -49.78
Net Income -162.956 -131.935 -121.492 -68.299 -49.78
Total Adjustments to Net Income 0 0 42.168 -17.163 -23.3
Income Available to Common Excl. Extra. Items -162.956 -131.935 -79.324 -85.462 -73.08
Income Available to Common Incl. Extra. Items -162.956 -131.935 -79.324 -85.462 -73.08
Diluted Net Income -162.956 -131.935 -79.324 -85.462 -73.08
Diluted Weighted Average Shares 48.161 45.589 42.722 45.2225 45.2225
Diluted EPS Excluding Extraordinary Items -3.38357 -2.89401 -1.85675 -1.88981 -1.61601
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -3.36512 -2.89401 -1.82007 -1.88981 -1.61601
Unusual Expense (Income) 1.367 0 1.567
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 36.04 33.467 32.007 27.761 25.057
Revenue 36.04 33.467 32.007 27.761 25.057
Cost of Revenue, Total 28.337 27.039 26.734 23.425 21.275
Gross Profit 7.703 6.428 5.273 4.336 3.782
Total Operating Expense 79.518 76.952 73.198 68.76 68.778
Selling/General/Admin. Expenses, Total 36.275 36.12 33.653 32.276 33.982
Research & Development 14.906 13.793 11.444 13.059 13.521
Operating Income -43.478 -43.485 -41.191 -40.999 -43.721
Interest Income (Expense), Net Non-Operating -0.435 -0.294 -0.189 0.238 -0.022
Other, Net 0
Net Income Before Taxes -43.913 -43.779 -41.38 -40.761 -43.743
Net Income After Taxes -44.046 -43.971 -41.444 -40.781 -43.839
Net Income Before Extra. Items -44.046 -43.971 -41.444 -40.781 -43.839
Net Income -44.046 -43.971 -41.444 -40.781 -43.839
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items -44.046 -43.971 -41.444 -40.781 -43.839
Income Available to Common Incl. Extra. Items -44.046 -43.971 -41.444 -40.781 -43.839
Diluted Net Income -44.046 -43.971 -41.444 -40.781 -43.839
Diluted Weighted Average Shares 48.951 48.783 49.139 48.129 47.882
Diluted EPS Excluding Extraordinary Items -0.8998 -0.90136 -0.8434 -0.84733 -0.91556
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.8998 -0.90136 -0.82532 -0.84733 -0.91556
Unusual Expense (Income) 1.367
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 373.645 409.802 345.911 79.646 147.646
Cash and Short Term Investments 287.502 339.488 314.87 69.378 142.782
Cash & Equivalents 73.222 182.348 294.972 36.226 33.264
Short Term Investments 214.28 157.14 19.898 33.152 109.518
Total Receivables, Net 28.07 25.6 6.468 3.914 1.088
Accounts Receivable - Trade, Net 28.07 25.6 6.468 3.914 1.088
Total Inventory 51.476 39.185 18.384 4.596 3.022
Prepaid Expenses 6.597 5.529 6.189 1.058 0.754
Total Assets 400.115 463.464 403.829 88.366 151.13
Property/Plant/Equipment, Total - Net 21.993 20.195 23.251 7.895 2.926
Property/Plant/Equipment, Total - Gross 32.8 27.849 28.239 10.565 5.149
Accumulated Depreciation, Total -10.807 -7.654 -4.988 -2.67 -2.223
Other Long Term Assets, Total 4.477 33.467 34.667 0.825 0.558
Total Current Liabilities 51.949 51.695 36.692 24.91 10.213
Accounts Payable 0.603 1.763 4.948 4.96 3.373
Accrued Expenses 35.575 39.575 26.578 10.43 5.349
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 7.509 0.01
Other Current Liabilities, Total 15.771 10.357 5.166 2.011 1.481
Total Liabilities 154.125 89.383 75.22 51.107 46.796
Total Long Term Debt 96.336 29.762 29.674 21.561 28.355
Long Term Debt 96.336 29.762 29.674 21.561 28.346
Capital Lease Obligations 0 0.009
Other Liabilities, Total 5.84 7.926 8.854 4.636 8.228
Total Equity 245.99 374.081 328.609 37.259 104.334
Redeemable Preferred Stock 0 0 0 409.446 392.284
Common Stock 0.048 0.047 0.043 0.007 0.006
Additional Paid-In Capital 1035.46 1000.21 822.624 0.356 0
Retained Earnings (Accumulated Deficit) -788.95 -625.994 -494.059 -372.572 -287.896
Unrealized Gain (Loss) -0.564 -0.184 0.001 0.022 -0.06
Total Liabilities & Shareholders’ Equity 400.115 463.464 403.829 88.366 151.13
Total Common Shares Outstanding 48.465 47.241 42.722 45.2225 45.2225
Other Current Assets, Total 0.7
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 283.774 309.404 337.275 373.645 310.003
Cash and Short Term Investments 193.998 222.791 249.213 287.502 227.517
Cash & Equivalents 36.297 36.388 36.386 73.222 63.877
Short Term Investments 157.701 186.403 212.827 214.28 163.64
Total Receivables, Net 35.493 36.902 34.314 28.07 22.512
Accounts Receivable - Trade, Net 35.493 36.902 34.314 28.07 22.512
Total Inventory 48.257 44.495 47.733 51.476 55.26
Prepaid Expenses 6.026 5.216 6.015 6.597 4.714
Total Assets 307.551 334.442 362.665 400.115 365.722
Property/Plant/Equipment, Total - Net 19.487 20.581 21.012 21.993 22.022
Other Long Term Assets, Total 4.29 4.457 4.378 4.477 33.697
Total Current Liabilities 53.024 48.824 44.268 51.949 49.644
Accounts Payable 2.88 2.217 1.988 0.603 1.444
Accrued Expenses 34.66 30.846 27.957 35.575 34.041
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 15.484 15.761 14.323 15.771 14.159
Total Liabilities 155.488 151.334 146.379 154.125 86.619
Total Long Term Debt 96.784 96.629 96.48 96.336 29.828
Long Term Debt 96.784 96.629 96.48 96.336 29.828
Other Liabilities, Total 5.68 5.881 5.631 5.84 7.147
Total Equity 152.063 183.108 216.286 245.99 279.103
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.05 0.05 0.049 0.048 0.048
Additional Paid-In Capital 1075.41 1060.42 1049.27 1035.46 1027.49
Retained Earnings (Accumulated Deficit) -923.147 -876.967 -832.921 -788.95 -747.506
Unrealized Gain (Loss) -0.253 -0.393 -0.113 -0.564 -0.934
Total Liabilities & Shareholders’ Equity 307.551 334.442 362.665 400.115 365.722
Total Common Shares Outstanding 50.173 49.629 49.216 48.465 48.295
Current Port. of LT Debt/Capital Leases
Property/Plant/Equipment, Total - Gross 32.8
Accumulated Depreciation, Total -10.807
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -162.956 -131.935 -121.492 -68.299 -49.78
Cash From Operating Activities -145.729 -130.264 -99.015 -70.292 -46.442
Cash From Operating Activities 5.169 5.162 3.159 1.484 1.069
Non-Cash Items 33.2 22.112 25.167 -1.878 2.486
Cash Taxes Paid 0.385 0.083 0.019 0.035 0.009
Changes in Working Capital -21.142 -25.603 -5.849 -1.599 -0.217
Cash From Investing Activities -66.295 -142.507 3.947 74.297 -68.776
Capital Expenditures -8.325 -3.108 -9.108 -3.293 -1.766
Other Investing Cash Flow Items, Total -57.97 -139.399 13.055 77.59 -67.01
Cash From Financing Activities 72.898 160.147 385.682 0.249 134.872
Financing Cash Flow Items -0.181 0
Issuance (Retirement) of Stock, Net 8.042 160.147 387.046 0.439 134.881
Issuance (Retirement) of Debt, Net 64.856 0 -1.364 -0.009 -0.009
Net Change in Cash -139.126 -112.624 290.614 4.254 19.654
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -43.971 -162.956 -121.512 -80.731 -36.892
Cash From Operating Activities -44.756 -145.729 -111.222 -76.91 -38.335
Cash From Operating Activities 1.384 5.169 3.9 2.586 1.262
Non-Cash Items 8.598 33.2 23.826 15.118 6.581
Cash Taxes Paid 0.201 0.385 0.334 0.283 0.205
Changes in Working Capital -10.767 -21.142 -17.436 -13.883 -9.286
Cash From Investing Activities 2.643 -66.295 -14.547 -34.706 -33.39
Capital Expenditures -0.81 -8.325 -6.216 -3.475 -1.478
Other Investing Cash Flow Items, Total 3.453 -57.97 -8.331 -31.231 -31.912
Cash From Financing Activities 5.277 72.898 7.298 4.765 3.723
Issuance (Retirement) of Stock, Net 5.277 8.042 7.433 4.765 3.723
Issuance (Retirement) of Debt, Net 64.856
Net Change in Cash -36.836 -139.126 -118.471 -106.851 -68.002
Financing Cash Flow Items -0.135

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Outset Medical, Inc. Company profile

About Outset Medical Inc

Outset Medical, Inc. is a medical technology company that offers Tablo. Tablo is a mobile integrated hemodialysis solution for acute and home hemodialysis therapy. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels and allows providers to access a single platform from the hospital to the home. The Tablo cartridge is a single use consumable intended to facilitate extracorporeal blood purification for patients and consists of a pre-configured blood, saline, and infusion tubing. Tablo’s touch screen panel enables the user to navigate through the treatment with animations and non-technical language, tailored to both professional and non-professional users. Tablo’s cloud connectivity software enables an ecosystem of machine diagnostics and analytics, treatment instruction, monitoring and reporting, improved documentation and remote machine management. In addition, Tablo also delivers robust clinical care.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Outset Medical Inc revenues increased from $49.9M to $102.6M. Net loss applicable to common stockholders increased 66% to $131.9M. Revenues reflect Consoles segment increase of 98% to $65.1M, Consumables segment increase from $6.7M to $19.2M. Higher net loss reflects Sales and marketing - Balancing value increase of 46% to $59.2M (expense).

Industry: Advanced Medical Equipment & Technology (NEC)

3052 Orchard Drive
SAN JOSE
CALIFORNIA 95134
US

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

ETH/USD

3,161.94 Price
+8.270% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

TSLA

172.44 Price
-0.890% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 0.13

XRP/USD

0.51 Price
+15.880% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

NVDA

880.87 Price
-2.750% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 0.42

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading